Inventor · disambiguated record
Sébastien Lacroix-Desmazes
Also filed as: LACROIX-DESMAZES SEBASTIEN · LACROIX-DESMAZES SÉBASTIEN
3 granted patents·11 pending applications·6 citations·filing 2000–2022
57Inventor score
Files withINST NAT SANTE RECH MED9CHTOUROU ABDESSATAR SAMI1DBV TECH1INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE1KAVERI SRINIVAS1
Top patents by PatentIndex Score
14 records- 0171US8802620B2Demannosylated recombinant factor VIII for the treatment of patients with haemophilia ACHTOUROU ABDESSATAR SAMI·Filed 2008·Granted Aug 12, 2014·6 cites·16 claims
- 0265US2023142731A1Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulinsINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0360US2020155658A1Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with fc-coupled antigensINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0459US2021246469A1Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulinsINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0559US2022175896A1Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with fc-coupled antigensINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0654US10507234B2Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with Fc-coupled antigensINST NAT SANTE RECH MED·Filed 2016·Granted Dec 17, 2019·0 cites·13 claims
- 0753US2021228738A1Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulinsINST NAT SANTE RECH MED·Filed 2017·Application pending·0 cites
- 0849US2009317373A1Inhibition of the Anti-FVIII Immune ResponseINST NAT SANTE RECH MED·Filed 2006·Application pending·0 cites
- 0942US2009208512A1Catalytic anti-factor VIII allo-antibodiesKAVERI SRINIVAS·Filed 2009·Application pending·0 cites
- 1039US2022047701A1Combination of her2/neu antibody with heme for treating cancerINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 1136US7507540B1Catalytic anti-factor VIII allo-antibodiesINST NAT SANTE RECH MED·Filed 2000·Granted Mar 24, 2009·0 cites·25 claims
- 1235US2017072032A1Prenatal therapy to induce immune toleranceINSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE)·Filed 2016·Application pending·0 cites
- 1335US2016220644A1Method of treating haemophilia by inducing tolerance to blood factorsDBV TECH·Filed 2016·Application pending·0 cites
- 1430US2017128544A1Uses of Humanized Cobra Venom Factor for Reducing or Preventing ImmunogenicityUNIV HAWAII·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sébastien Lacroix-Desmazes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →